SCM
HRTX icon

Sio Capital Management’s Heron Therapeutics HRTX Stock Holding History

Sio Capital Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-29,500
Closed -$814K – 52
2018
Q1 		$814K Buy
+29,500
New +$669K 0.49% 28

Other funds holding HRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Sio Capital Management's HRTX Position: Q1 2016 in Review

Sio Capital Management sold out of Heron Therapeutics (HRTX) in Q1 2016, closing a stake of 99,772 shares — an estimated $2.66M sold.

Sio Capital Management first reported a position in HRTX in Q1 2015 and held it in 2 quarters. The position peaked at $2.66M in Q4 2015. 99 funds tracked by Wall St. Rank hold HRTX as of Q1 2016.

  • Sio Capital Management reported no remaining Heron Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Sio Capital Management sold 99,772 Heron Therapeutics shares in Q1 2016, an estimated $2.66M.
  • Sio Capital Management first reported a position in Heron Therapeutics in Q1 2015 and held it in 2 quarters.
  • Sio Capital Management's Heron Therapeutics position peaked at $2.66M in Q4 2015.
  • 99 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2016.

Based on Sio Capital Management's 13F filing for Q1 2016, filed 16 May 2016.